M&A

Manus is considering overhauling its business structure to become a joint venture incorporated in China.

Manus original investors plan to buy back AI firm from Meta for US$2 billion: report

Early investors including HSG, ZhenFund and Tencent are participating in the buyback

The two companies have long shared executives and other resources and are jointly developing multibillion-dollar projects.

Elon Musk’s next move may be a megamerger of SpaceX and Tesla

Some shareholders might object, but there is little they could do, legal experts say

The ASX launched a review in 2025, after James Hardie was exempted from a shareholder vote when it issued about 35% of its shares to fund a takeover.

Australia’s ASX proposes 25% cap on share issuance in M&A without shareholder vote

This comes after pressure from investors who fear dilution of their ownership in buyouts

LongRange Capital will acquire Pizza Hut ex-China for US$1.5 billion.

Yum strikes two deals to sell Pizza Hut for US$2.7 billion in tale of diverging fortunes

Pizza Hut’s share of Yum’s revenue has declined every year since 2019

Goldman Sachs has retained its top ranking for global M&A advisor in 2026.

Goldman Sachs shatters dealmaking records with US$1 trillion in first-half M&A volume

The figure comes on the back of the investment bank managing SpaceX’s landmark IPO

Woodside is Australia’s largest LNG exporter, and is developing a project on the US Gulf Coast which is set to come online by 2029.

ExxonMobil studies takeover targets including Australia’s Woodside Energy

An LNG-focused deal has become a more serious priority since the start of the war in Iran in late February

BizLink says it plans to become a “one-stop shop” for integrated data centre solutions with this deal.

BizLink to buy Blackstone’s Singapore-based Interplex for US$850 million

Interplex Datacom makes the components that form the physical architecture of AI server racks

The transaction is expected to close later this year.

J&J to buy cancer drug technology developer Firefly Bio for US$1 billion

JOHNSON & Johnson said on Monday (Jun 8) it will acquire biotech Firefly Bio for US$1 billion in cash, as it looks to expand its cancer drug pipeline.